MannKind's Technosphere® Inhalation Platform Utilized

Tyvaso DPI represents the second FDA-approved product utilizing MannKind’s Technosphere® inhalation technologyFirst approval of a dry powder inhaled...

Related Keywords

United States , Connecticut , Brazil , Mannkind Afrezza , Michael Castagna , Mannkind Technosphere , Patrick Poisson , Mannkind Corporation , United Therapeutics Corporation , Mannkind Corporation Nasdaq , Drug Administration , United Therapeutics , Kind Corporation , United Therapeutic Tyvaso , Chief Executive Officer , Executive Vice President , Technical Operations , Inhalation Powder , Inhalation Solution , Arterial Hypertension , Inhalation System , Westlake Village , Nasdaq Mnkd , Mannkind ,